We are proud to announce that Dr Lyn Daintree, Development Director at CrystecPharma and a 2025 Women in Pharma Award winner, has been nominated for the Outstanding Contribution Award at the Making Pharmaceuticals Awards.
The Outstanding Contribution Award recognises individuals working across the pharmaceutical value chain, from drug discovery through to distribution, who demonstrate exceptional innovation, leadership, and influence in driving meaningful and positive change within the industry.
This nomination reflects Dr Daintree’s significant contributions to pharmaceutical development and her ongoing commitment to advancing innovation in the sector.
We warmly congratulate Dr Daintree on this well-deserved recognition and wish her every success at the awards.